Recruiting NA Schizophrenia Spectrum Disorders

New treatment option for Schizophrenia Spectrum Disorders

Official title MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI

ClinicalTrials.gov ID: NCT06138054

What this study is testing

What it's testing
This study aims to test the feasibility and acceptability of a brief behavioral intervention that combines two treatments, Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT), that have been shown to work in prior research studies. The format of the intervention will be a combination of in-person sessions and remote elements delivered via mobile phone (together called MI-CBTech).
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • Veterans currently residing at the VA Greater Los Angeles Mental Health Residential Rehabilitation Treatment Program (Domiciliary)
  • age 18-65 years
  • diagnosis of non-affective or affective psychotic illness as confirmed by chart review
  • history of homelessness
  • sufficiently fluent in English to consent, understand procedures, and complete assessments and intervention

You likely can't join if

  • history of clinically significant neurological disorder determined by medical history (e.g., epilepsy)
  • history of serious head injury (i.e., loss of consciousness \> 1 hr, neuropsychological sequelae, cognitive rehabilitation post head injury)
  • evidence of IQ \< 70 or developmental disability
  • moderate or severe substance use disorder in the past month based on chart review
See the full eligibility criteria
Who can join
  • Veterans currently residing at the VA Greater Los Angeles Mental Health Residential Rehabilitation Treatment Program (Domiciliary)
  • age 18-65 years
  • diagnosis of non-affective or affective psychotic illness as confirmed by chart review
  • history of homelessness
  • sufficiently fluent in English to consent, understand procedures, and complete assessments and intervention
  • medically and clinically stable (i.e. able to participate in and complete assessments and intervention).
What rules you out
  • history of clinically significant neurological disorder determined by medical history (e.g., epilepsy)
  • history of serious head injury (i.e., loss of consciousness \> 1 hr, neuropsychological sequelae, cognitive rehabilitation post head injury)
  • evidence of IQ \< 70 or developmental disability
  • moderate or severe substance use disorder in the past month based on chart review

The study team makes the final eligibility decision.

Where it's taking place

  • West Los Angeles, California, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include West Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.